Toward an in Vivo Neurochemical Profile: Quantification of 18 Metabolites in Short-Echo-Time 1H NMR Spectra of the Rat Brain

Journal of Magnetic Resonance

Volumn 141, Issue 1, 1999, Pages 104-120

  Pfeuffer, Josef ^a   Tkáč, Ivan ^a   Provencher, Stephen W ^b   Gruetter, Rolf ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

In vivo 1H NMR spectroscopy; LCModel; Macromolecules; Quantification; Rat brain; Short echo time

Indexed keywords

AMINO ACID;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BRAIN LEVEL; HEPATIC ENCEPHALOPATHY; HYPERGLYCEMIA; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; RAT; REPRODUCIBILITY; SPRAGUE DAWLEY RAT;

AMINO ACIDS; ANIMALS; BRAIN CHEMISTRY; HEPATIC ENCEPHALOPATHY; HYPERGLYCEMIA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MODELS, BIOLOGICAL; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS;

EID: 0033226834     PISSN: 10907807     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmre.1999.1895     Document Type: Article

References (65)

1. F. A. Howe, R. J. Maxwell, D. E. Saunders, M. M. Brown, and J. R. Griffiths, Proton spectroscopy in vivo, Magn. Reson. Q. 9, 31-59 (1993).
2. B. D. Ross and T. Michaelis, Clinical applications of magnetic resonance spectroscopy, Magn. Reson. Q. 10, 191-247 (1994).
3. M. W. Weiner, H. P. Hetherington, B. Hubesch, G. Karczmar, B. Massie, A. A. Maudsley, D. J. Meyerhoff, D. Sappey-Marinier, S. Schaefer, and D. B. Twieg, Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. [Review], NMR Biomed. 2, 290-297 (1989).
4. D. G. Gadian, T. E. Bates, S. R. Williams, J. D. Bell, S. J. Austin, and A. Connelly, Approaches to editing, assignment and interpretation of proton spectra, NMR Biomed. 4, 85-89 (1991).
5. S. R. Williams, Cerebral amino acids studied by nuclear magnetic resonance spectroscopy in vivo, Prog. NMR Spectrosc. 34, 301-326 (1999).
6. J. A. Stanley, D. J. Drost, P. C. Williamson, and R. T. Thompson, The use of a priori knowledge to quantify short echo in vivo 1H MR spectra, Magn. Reson. Med. 34, 17-24 (1995).
7. J. H. Hwang, G. D. Graham, K. L. Behar, J. R. Alger, J. W. Prichard, and D. L. Rothman, Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain, Magn. Reson. Med. 35, 633-639 (1996).
8. D. E. Saunders, F. A. Howe, A. van den Boogaart, J. R. Griffiths, and M. M. Brown, Discrimination of metabolite from lipid and macromolecule resonances in cerebral infarction in humans using short echo proton spectroscopy, J. Magn. Reson. Imaging 7, 1116-1121 (1997).
9. P. J. Pouwels and J. Frahm, Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS, NMR Biomed. 10, 73-78 (1997).
10. W. Willker, J. Engelmann, A. Brand, and D. Leibfritz, Metabolite identification in cell extracts and culture media by proton-detected 2D-H,C-NMR spectroscopy, J. Magn. Reson. Anal. 2, 21-32 (1996).
11. 1H magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus, Neurology 43, 589-594 (1993).
12. 1H NMR detection of cerebral myo-inositol, FEBS Lett. 187, 167-172 (1985).
13. O. A. Petroff, T. Ogino, and J. R. Alger, High-resolution proton magnetic resonance spectroscopy of rabbit brain: Regional metabolite levels and postmortem changes, J. Neurochem. 51, 163-171 (1988).
14. 1H NMR spectrum of rat brain, Magn. Reson. Med. 30, 38-44 (1993).
15. W. Dreher and D. Leibfritz, On the use of two-dimensional-J NMR measurements for in vivo proton MRS: Measurement of homonuclear decoupled spectra without the need for short echo times, Magn. Reson. Med. 34, 331-337 (1995).
16. I. M. Brereton, G. J. Galloway, S. E. Rose, and D. M. Doddrell, Localized two-dimensional shift correlated spectroscopy in humans at 2 Tesla, Magn. Reson. Med. 32, 251-257 (1994).
17. 13C-NMR, Magn. Reson. Med. 39, 313-316 (1998).
18. R. de Beer and D. van Ormondt, Analysis of NMR data using time domain fitting procedures, NMR Basic Princ. Prog. 26, 201-248 (1992).
19. S. Mierisova, A. van den Boogaart, I. Tkac, P. Van Hecke, L. Vanhamme, and T. Liptaj, New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES, NMR Biomed. 11, 32-39 (1998).
20. S. W. Provencher, Estimation of metabolite concentrations from localized in vivo proton NMR spectra, Magn. Reson. Med. 30, 672-679 (1993).
21. J. Slotboom, C. Boesch, and R. Kreis, Versatile frequency domain fitting using time domain models and prior knowledge, Magn. Reson. Med. 39, 899-911 (1998).
22. R. Stoyanova, A. C. Kuesel, and T. R. Brown, Application of principal-component analysis for NMR spectral quantitation, J. Magn. Reson. A 115, 265-269 (1995).
23. B. J. Soher, K. Young, V. Govindaraju, and A. A. Maudsley, Automated spectral analysis III: Application to in vivo proton MR spectroscopy and spectroscopic imaging, Magn. Reson. Med. 40, 822-831 (1998).
24. G. J. Metzger, M. Patel, and X. Hu, Application of genetic algorithms to spectral quantification, J. Magn. Reson. B 110, 316-320 (1996).
25. O. M. Weber, C. O. Duc, D. Meier, and P. Boesiger, Heuristic optimization algorithms applied to the quantification of spectroscopic data, Magn. Reson. Med. 39, 723-730 (1998).
26. 1H NM R spectra with increased magnetic field strength, J Magn. Reson. 135, 260-264 (1998).
27. 1H NMR spectroscopy of rat brain at 1 ms echo time, Magn. Reson. Med. 41, 649-656 (1999).
28. M. Terpstra, P. M. Andersen, and R. Gruetter, Localized eddy current compensation using quantitative field mapping, J. Magn. Reson. 131, 139-143 (1998).
29. G. Adriany and R. Gruetter, A half-volume coil for efficient proton decoupling in humans at 4 Tesla, J. Magn. Reson. 125, 178-184 (1997).
30. A. Tannus and M. Garwood, Improved performance of frequency-swept pulses using offset-independent adiabaticity, J. Magn. Reson. A 120, 133-137 (1996).
31. R. Gruetter, Automatic, localized in vivo adjustment of all first- and second-order shim coils, Magn. Reson. Med. 29, 804-811 (1993).
32. W. W. F. Pijnappel, A. van den Boogaart, R. de Beer, and D. van Ormondt, SVD-based quantification of magnetic resonance signals, J. Magn. Reson. 97, 122-134 (1992).
33. H. McIlwain and H. S. Bachelard, "Biochemistry and the Central Nervous System," 5th ed., Churchill Livingstone, Edinburgh (1985).
34. T. L. Perry, Cerebral amino acid pools, in "Handbook of Neurochemistry" (A. Lajtha, Ed.), 2nd ed., Vol. 1, pp. 151-180, Plenum Press, New York (1982).
35. D. D. Clarke, A. L. Lajtha, and H. S. Maher, Intermediary metabolism, in "Basic Neurochemistry" (G. J. Siegel, Ed.), pp. 541-564, Raven, New York (1989).
36. R. L. Veech, R. L. Harris, D. Veloso, and E. H. Veech, Freeze-blowing: A new technique for the study of brain in vivo, J. Neurochem. 20, 183-188 (1973).
37. A. M. Mans, M. R. DeJoseph, and R. A. Hawkins, Metabolic abnormalities and grade of encephalopathy in acute hepatic failure, J. Neurochem. 63, 1829-1838 (1994).
38. D. Holowenko, J. Peeling, and G. Sutherland, 1H NMR properties of N-acetylaspartylglutamate in extracts of nervous tissue of the rat, NMR Biomed. 5, 43-47 (1992).
39. R. K. Shaw and J. D. Heine, Effect of insulin on nitrogenous constituents of rat brain, J. Neurochem. 12, 527-532 (1965).
40. L. Battistin and A. Lajtha, Regional distribution and movement of amino acids in the brain, J. Neurol. Sci. 10, 313-322 (1970).
41. Y. Nagatomo, M. Wick, F. Prielmeier, and J. Frahm, Dynamic monitoring of cerebral metabolites during and after transient global ischemia in rats by quantitative proton NMR spectroscopy in vivo, NMR Biomed. 8, 265-270 (1995).
42. B. D. Ross, E. R. Danielsen, and S. Bluml, Proton magnetic resonance spectroscopy: The new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy?, Dig. Dis. 14(Suppl. 1), 30-39 (1996).
43. 1H MR spectra in vivo at short echo times with baseline distortion, Proc. ISMRM, 5th Sci. Meet., Vancouver. 1411 (1997).
44. D. L. Rothman, K. L. Behar, J. W. Prichard, and O. A. Petroff, Homocarnosine and the measurement of neuronal pH in patients with epilepsy, Magn. Reson. Med. 38, 924-929 (1997).
45. 1H NMR spectra of human brain, Magn. Reson. Med. 32, 294-302 (1994).
46. M. Mescher, H. Merkle, J. Kirsch, M. Garwood, and R. Gruetter, Simultaneous in vivo spectral editing and water suppression, NMR Biomed. 11, 266-272 (1998).
47. 1H NMR, Magn. Reson. Med. 7, 425-431 (1988).
48. 1H relaxation in normal and hyponatremic brain, Magn. Reson. Med. 35, 688-696 (1996).
49. 1H NMR spectroscopy in vivo, NMR Biomed. 7, 231-236 (1994).
50. 1H-containing metabolites in rat brain after focal ischemia, NMR Biomed. 8, 245-252 (1995).
51. 1H NMR spectroscopy of brain glucose and metabolites, Magma 6(Suppl. 1), 9 (1998).
52. R. Gruetter, K. Ugurbil, and E. R. Seaquist, Steady-state cerebral glucose concentrations and transport in the human brain, J. Neurochem. 70, 397-408 (1998).
53. A. Ziegler, M. Izquierdo, C. Remy, and M. Decorps, Optimization of homonuclear two-dimensional correlation methods for in vivo and ex vivo NMR, J. Magn. Reson. B 107, 10-18 (1995).
54. 31P NMR resonance peak of phosphoethanolamine, Magn. Reson. Med. 6, 99-106 (1988).
55. 31P NMR phosphomonoester and biochemically determined phosphorylethanolamine and phosphatidylethanolamine during development of the rat brain, Dev. Neurosci. 10, 213-221 (1988).
56. 1H NMR spectroscopy, J. Magn. Reson. B 113, 184-189 (1996).
57. 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy, J. Neurochem. 71, 1564-1576 (1998).
58. R. E. Hurd, D. Gurr, and N. Sailasuta, Proton spectroscopy without water suppression: The oversampled J- resolved experiment, Magn. Reson. Med. 40, 343-347 (1998).
59. W. Dreher and D. Leibfritz, Detection of homonuclear decoupled in vivo proton NMR spectra using constant time chemical shift encoding: CT-PRESS, Magn. Reson. Imaging 17, 141-150 (1999).
60. 1H NMR spectra of the human brain at 4 Tesla, Magn. Reson. Med. 36, 1-6 (1996).
61. 1H NMR studies of glucose transport in the human brain, J. Cereb. Blood Flow Metab. 16, 427-438 (1996).
62. 1H spectroscopic imaging data sets, NMR Biomed. 5, 171-178 (1992).
63. 13C] D-glucose, Magn. Reson. Med. 41, 1077-1083 (1999).
64. 1H spectroscopy in human brain at 4 Tesla, Magn. Reson. Med. 33, 246-252 (1995).
65. H. P. Hetherington, J. W. Pan, W. J. Chu, G. F. Mason, and B. R. Newcomer, Biological and clinical MRS at ultra-high field, NMR Biomed. 10, 360-371 (1997).